E-ISSN 2231-3206 | ISSN 2320-4672

2017, Vol:7,Issue:8

Research Articles
  • Natl J Physiol Pharm Pharmacol.2017; Volume:7(8):860-864 doi : 10.5455/njppp.2017.7.0410801052017
  • Antihyperglycemic effects of Cajanus cajan L. (pigeon pea) ethanolic extract on the blood glucose levels of ICR mice (Mus musculus L.)
  • Jose Alberto Manapil Manzo, Rodel Jonathan Santos Vitor II

Abstract

Background: Diabetes mellitus is a metabolic disease that is usually associated with abnormalities in the metabolism of different substrates leading to high blood glucose levels (BGL). Aims and Objectives: Aims and objectives are to evaluate the effects of ethanolic extracts of Cajanus cajan (CCEE) leaves on its antihyperglycemic effects on BGL of normoglycemic mice.
Materials and Methods: 45, 5-week-old female, mice were divided into five groups and were administered with either double distilled water, glimepiride, or CCEE.
Results: Baseline BGLs were measured before the induction of hyperglycemia by glucose loading. 30 min after, the BGLs were measured again and ranged between 167.667 and 185.778 mg/dL. Immediately after the hyperglycemic BGLs were measured, the corresponding treatments were administered. Subsequently, three blood collections were done spanning 3 h with 1 h interval. The treatment doses were observed to have a faster onset than the positive control supported by the fact that the treatment groups had significant st differences (P < 0.05) with their respective hyperglycemic BGLs on the 1 h, while the positive control group exhibited nd significant difference with its hyperglycemic BGL on the 2 h. The hypoglycemic effect of the positive control peaked at rd the 3 h with 67.33 mg/dL and surpassed the hypoglycemic effect of the medium- and high-dose groups with 83.778 and 98.556 mg/dL, respectively. The low-dose group did not have significant difference with the negative control group past st the 1 h suggesting that this dosage has a weak hypoglycemic effect. Conclusion: These results indicate that the CCEE leaves were able to produce hypoglycemic effects at doses between 400 and 800 mg/kg bodyweight.